BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31911122)

  • 1. Renal Neuroendocrine Neoplasms: A Single-center Experience.
    McGarrah PW; Westin GFM; Hobday TJ; Scales JA; Ingimarsson JP; Leibovich BC; Halfdanarson TR
    Clin Genitourin Cancer; 2020 Aug; 18(4):e343-e349. PubMed ID: 31911122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine tumors of the kidney: a single institution experience.
    Teegavarapu PS; Rao P; Matrana M; Cauley DH; Wood CG; Tannir NM
    Clin Genitourin Cancer; 2014 Dec; 12(6):422-7. PubMed ID: 25088468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years.
    Desai GS; Pande P; Chhabra V; Shah RC; Jagannath P
    Indian J Gastroenterol; 2019 Oct; 38(5):399-410. PubMed ID: 31802438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum.
    Smith JD; Reidy DL; Goodman KA; Shia J; Nash GM
    Ann Surg Oncol; 2014 Sep; 21(9):2956-62. PubMed ID: 24763982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.
    Matrood S; Apostolidis L; Schrader J; Krug S; Lahner H; Ramaswamy A; Librizzi D; Kender Z; Kröcher A; Kreutzfeldt S; Gress TM; Rinke A
    Front Endocrinol (Lausanne); 2021; 12():709256. PubMed ID: 34690926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
    Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
    J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
    Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
    Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular adnexal manifestations of neuroendocrine neoplasms: a case report and a major review.
    Hatsis AJ; Henry RK; Curtis MT; Bilyk JR; Sivalingam MD; Eagle RC; Milman T
    Orbit; 2021 Dec; 40(6):488-498. PubMed ID: 33140682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors.
    Nandy K; Patkar S; Yadav S; Ostwal V; Ramaswamy A; Bhargav P; Goel M
    J Surg Oncol; 2024 May; 129(6):1121-1130. PubMed ID: 38348696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
    Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3.
    Merola E; Falconi M; Rinke A; Staettner S; Krendl F; Partelli S; Andreasi V; Gress TM; Pascher A; Arsenic R; Doglioni C; Kaemmerer D; Wiedenmann B; Pavel ME
    Am J Surg; 2020 Aug; 220(2):284-289. PubMed ID: 32209239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
    Saxena A; Chua TC; Zhao J; Morris DL
    J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
    Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
    Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.
    Kim SJ; Kim JW; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Seog Heo D; Bang YJ
    BMC Cancer; 2010 Aug; 10():448. PubMed ID: 20731845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.